More Orthocell Ltd news
Orthocell LtdASX: OCC

Ethics Approval Received for Pilot Ortho-ATI Tendon Study

Apr 30, 2017 at 11:30 PM EDT · Issued by Orthocell Ltd

Filed with ASX · Apr 30, 2017 at 11:30 PM EDT

On 6ix: 6ix.com/news/ethics-approval-received-for-pilot-ortho-ati-tendon-study

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Story so far

  • Singapore Patent for CelGro SMART Graft ReceivedMar 28, 2017
  • Approval for CelGro Human Nerve Regeneration Study ReceivedOct 18, 2016
  • Ethics Approval for Pivotal Ortho ATI Tendon Study ReceivedJul 12, 2016

Earlier from Orthocell

  • Response to ASX QueryApr 10, 2017
  • Singapore Patent for CelGro SMART Graft ReceivedMar 27, 2017
  • Orthocell Announces Gluteal Tendon PublicationFeb 26, 2017
  • Initial Results Positive for CelGro Human Nerve RegenerationFeb 21, 2017
  • Orthocell Submits US Regulatory Application for CelGroFeb 7, 2017

Later from Orthocell

  • Ortho-ACI on Australian Register of Therapeutic GoodsMay 29, 2017
  • Preliminary Final ReportAug 31, 2017
  • 1st Patient Recruited in Ortho-ATI Shoulder Tendon StudySep 4, 2017
  • Celgro Positive Safety and Performance in Human Hip StudySep 5, 2017
  • Surgical Specialties Appointed as Exclusive DistributorOct 10, 2017
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer